Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3526 |
|
| Actual shortage: | 229 (6%) | |
| Anticipated shortage: | 3 (0%) | |
| Avoided shortage: | 11 (0%) | |
| Resolved: | 3283 (93%) | |
Discontinuation Reports |
366 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 342 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
143 (4%) |
|
Overdue reports |
32 (13%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-CLOPIDOGREL | 75MG | TABLET | Resolved | 2023-04-21 | 2023-05-06 | 189994 |
| APO-CLOPIDOGREL | 300MG | TABLET | Resolved | 2023-08-12 | 2023-11-17 | 201716 |
| APO-CLOPIDOGREL | 300MG | TABLET | Resolved | 2024-01-12 | 2024-03-15 | 215970 |
| APO-CLOPIDOGREL | 300MG | TABLET | Resolved | 2024-05-24 | 2024-07-05 | 228813 |
| APO-CLOPIDOGREL | 75MG | TABLET | Resolved | 2024-08-15 | 2024-10-04 | 235348 |
| APO-CLOPIDOGREL | 75MG | TABLET | Resolved | 2024-10-18 | 2024-11-29 | 240616 |
| APO-CLOPIDOGREL | 300MG | TABLET | Resolved | 2024-11-21 | 2025-01-03 | 243623 |
| APO-CLOPIDOGREL | 75MG | TABLET | Resolved | 2025-02-06 | 2025-05-02 | 249749 |
| APO-CLOPIDOGREL | 300MG | TABLET | Resolved | 2025-03-27 | 2025-06-16 | 253499 |
| APO-CLOPIDOGREL | 75MG | TABLET | Resolved | 2025-04-17 | 2025-09-19 | 255205 |
| APO-CLOPIDOGREL | 75MG | TABLET | Resolved | 2025-05-15 | 2025-10-16 | 257406 |
| APO-CLOPIDOGREL | 75MG | TABLET | Resolved | 2025-05-22 | 2025-06-16 | 258172 |
| APO-CLOPIDOGREL | 300MG | TABLET | Resolved | 2025-07-10 | 2025-08-29 | 262402 |
| APO-CLOPIDOGREL | 300MG | TABLET | Actual shortage | 2025-10-10 | 2025-12-04 | 269317 |
| APO-CLOPIDOGREL | 75MG | TABLET | Resolved | 2025-11-13 | 2025-12-05 | 271844 |
| APO-CLOPIDOGREL | 75MG | TABLET | Resolved | 2025-11-13 | 2025-12-05 | 271850 |
| APO-CLOPIDOGREL | 75MG | TABLET | Resolved | 2025-11-20 | 2025-12-05 | 272341 |
| APO-COLESEVELAM | 625MG | TABLET | Resolved | 2022-03-11 | 2022-04-01 | 156537 |
| APO-COLESEVELAM | 625MG | TABLET | Resolved | 2022-11-04 | 2023-02-09 | 173826 |
| APO-COLESEVELAM | 625MG | TABLET | Resolved | 2023-04-21 | 2023-07-27 | 190011 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-TIMOP | 0.5% | SOLUTION | Discontinued | 2019-01-03 | 2019-01-03 | 70894 |
| APO-TIMOP GEL | Discontinued | 2019-01-03 | 2019-01-03 | 71020 | ||
| APO-TIMOP | Discontinued | 2019-01-02 | 2019-01-02 | 70818 | ||
| APO-TOLTERODINE | 1MG | TABLET | Discontinued | 2018-09-08 | 2019-01-17 | 60822 |
| APO-TOLTERODINE | 2MG | TABLET | Discontinued | 2018-09-08 | 2018-11-09 | 60825 |
| APO-TOLTERODINE | 2MG | TABLET | Discontinued | 2018-09-08 | 2019-06-12 | 60828 |
| APO-TRAZODONE TABLETS 100MG | 100MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60831 |
| APO-TRAZODONE TABLETS 50MG | 50MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60834 |
| APO-VALACYCLOVIR | 500MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60840 |
| APO-VALGANCICLOVIR | 450MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60843 |
| APO-VALPROIC ACID ORAL SOLUTION | 250MG | SOLUTION | Discontinued | 2023-09-26 | 2023-11-02 | 205310 |
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71029 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71032 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71035 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71038 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71044 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71048 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71051 | ||
| APO-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71054 |
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71057 |